New pancreatic cancer drug nearly doubles survival time in patients

The Independent — Apr 13, 16:38 PM

Pancreatic cancer is the only cancer with a five-year survival rate that’s below 20%

Read full article at The Independent →

Revolution Medicines' cancer drug success

U.S. Markets Rose Monday; Revolution Medicines Topped Leaders
Barrons — Apr 13, 20:10 PM
Revolution Medicines' experimental cancer pill boosts survival in late-stage study - Reuters
Reuters — Apr 13, 14:09 PM
This Biotech Stock Soars 38%. Pancreatic Cancer Trial Was a Success.
Barrons — Apr 13, 13:11 PM
Revolution Medicines' potential breakthrough pancreatic cancer drug succeeds in late-stage trial
CNBC — Apr 13, 12:04 PM